Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Experience with hemoadsorption (CytoSorb ® ) in the management of septic shock patients.

Yatin Mehta,Chitra Mehta,Ashish Kumar,Joby Varghese George,Aditi Gupta,Saurabh Nanda, Gourav Kochhar, Arun Raizada

World journal of critical care medicine（2020）

Cited 33|Views3
No score
Abstract
CytoSorb is a safe and well tolerated rescue therapy option in patients with septic shock. However, early (preferably within < 48 h after onset of septic shock) initiation could result in better clinical outcomes. Further randomized trials are needed to define the potential benefits of this new treatment modality.
More
Translated text
Key words
Clinical conditions,Cytokines,Hemoadsorption,Inflammation and extracorporeal,Sepsis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined